Cryptococcal meningitis in Rio de Janeiro State, Brazil, 1994-2004

Cadernos de Saude Publica

Volumn 24, Issue 11, 2008, Pages 2582-2592

  Leimann, Beatriz Consuelo Quinet ^a   Koifman, Rosalina Jorge ^b  

^a Instituto Estadual de Infectologia Sao Sebastiao   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cryptococcal meningitis; Epidemiologic surveillance; Incidence rate

Indexed keywords

EID: 56349092399     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2008001100013     Document Type: Article

References (43)

1. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect. Dis 2000; 31:499-508.
2. Kwon-Chung KJ, Varma A. Do major species concepts support, one, two or more species within Cryptococcus neoformans? FEMS Yeast Res 2006; 6:574-87.
3. Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RCL, et al. Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J Clin Microbiol 2003; 41:73-7.
4. Oliveira-Netto IC, Machado CC, Wagner MB, Severo LC. Melo século de criptococose no Brasil: revisão de 308 casos (1941-1992). Âmbito Hosp 1993; 7:5-16.
5. Tintelnot K, Lemmer K, Losert H, Schär G, Polak A. Follow-up of epidemiological data of cryptococcosis in Austria, Germany, and Switzerland with special focus on the characterization of clinical isolates. Mycoses 2004; 47:455-64.
6. Lacaz CS, Porto E, Martins JEC, Heins-Vaccari, Melo NT. Criptococose. In: Lacaz CS, Porto E, Martins JEC, Heins-Vaccari EM, Melo NT, organizadores. Tratado de micologia médica Lacaz. São Paulo: Editora Sarvier; 2002. p. 416.
7. Pappalardo MCSM, Melhem MSC. Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop São Paulo 2003; 45:299-305.
8. Dromer F, Mathoulin-Péllissier S, Fontanet A, Ronin O, Dupont B, Lortholary O. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART era. AIDS 2004; 18:555-62.
9. Guimarães MDC. Estudo temporal das doenças associadas à AIDS no Brasil, 1980-1999. Cad Saúde Pública 2000; 16 Suppl 1:S21-36.
10. Manfred! R, Pieri F, Pileri AS. The changing face of AIDS related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review. Mycopathologia 1999; 148:73-8.
11. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002; 16:837-74.
12. Division of Bacterial and Mycotic Diseases, Centers for DiseaseControl andPrevention. Cryptococcosis. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/crypt. ococcosis_t.htm (accessed on Dec/2005).
13. ChrétienF LortholaryO, Kansaul, Neuville S, Gray F, Dromer F. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 2002; 186:522-30.
14. Fessler RD, Sobel J, Guyot L, Crane L, Vazquez J, Szuba J, et al. Management of elevated intracranial pressure in patients with Cryptococcal meningitis. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:137-42.
15. Hamill RJ. Cryptococcosis. In: Tierney LM, McPhee SJ, Papadakis M, editors. Current medical diagnosis and treatment. 42nd Ed. New York: Lange Medical Books/MacGraw-Hill; 2003. p. 1487-8.
16. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 1999; 179:449-54.
17. Carvalho FS. Estudo comparativo da criptococose em pacientes aparentemente imunocompetentes, com SIDA ou com outras formas de imunodeficiência [Masters Thesis]. Ribeirão Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo; 2003.
18. Martins LMS. Epidemiologia da criptococose em crianças e diversidade da Cryptococcus neoformans no meio norte do Brasil [Masters Thesis]. Rio de Janeiro: Instituto Oswaldo Cruz, Fundação Oswaldo Cruz; 2003.
19. Gonçalves AJR, Lopes PFA, Pinto AMM, Lazera M, Menezes JA, Cunha RQ, et. al. Criptococose: estudo de 27 casos observados no Hospital dos Servidores do Estado - INAMPS e no Hospital São Sebastião - Rio de Janeiro. J Bras Med 1984; 46:43-63.
20. Rozembaum R, Gonçalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18:369-80.
21. Corrêa MPSC, Oliveira EC, Duarte RRBS, Pardal PPO, Oliveira FM, Severo LC. Criptococose em crianças no estado do Pará, Brasil. Rev Soc Bras Med Trop 1999; 32:505-8.
22. Py EA, Aloe M, Burlamaqui L, Guasti S, Monerat PJT. Relato de cinco casos de meningite criptocócica em crianças com a síndrome da imunodeficiência adquirida (AIDS). Arq Bras Pediatr 1997; 4:15-20.
23. Abadi J, Nachman S, Kressel AB. Cryptococcosis in children with AIDS. Clin Infect Dis 1999; 28:309-13.
24. Dados epidemiológicos - AIDS. Tabela II. Taxa de incidência (por 100.000 hab.) de AIDS segundo UF de residência por ano de diagnóstico, Brasil, 1994-2004. Boletim Epidemiológico AIDST 2005; Ano II, no. 1. p. 25.
25. Leimann BCQ. Epidemiologia da meningite criptocócica no Estado do Rio de Janeiro no período de 1994 a 2004 [Masters Thesis]. Rio de Janeiro: Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz; 2007.
26. Ministério da Saúde. Casos de AIDS identificados no Rio de Janeiro, http://www.aids.gov.br/cgi/tabcgi.exe?tabnet/RJ.def (accessed on Nov/2006).
27. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect. Dis Clin North Am 2006; 20:507-44, v- vi.
28. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36:789-94.
29. Friedman GD, Jeffrey Fessel W, Udaltsova NV Hurley LB. Cryptococcosis: the 1981-2000 epidemic. Mycoses 2005; 48:122-5.
30. van Elden LJR, Walenkamp AME, Lipovsky MM, Reiss P, Meis JFGM, Marie S, et al. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 2000; 14:2787-8.
31. Saraceni V, Cruz MM, Lauria LM, Durovni B. Trends and characteristics of AIDS mortality in the Rio de Janeiro city after the introduction of highly active antiretroviral therapy. Braz J Infect. Dis 2005; 9:209-15.
32. Pinto Jr. VL. Criptococose associada à AIDS: análise da casuística do Instituto de Pesquisa Clínica Evandro Chagas-Fiocruz entre 1987 e 2002 [Masters Thesis]. Rio de Janeiro: Fundação Oswaldo Cruz; 2003.
33. Ferreira NMB, Portela MC, Vasconcellos MTL. Fatores associados à subnotificação de pacientes com AIDS, no Rio de Janeiro. Rev Saúde Pública 2000; 34:170-7.
34. Livramento JA, Machado LR, Nóbrega JPS, Gomes HR, Vianna LS, Spina-França A. CSF in 85 patients with AIDS and CNS cryptococcosis. Arq Neuropsiquiatr 1992; 50:491-6.
35. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8:515-48.
36. Chequer P. Apresentação. Boletim Epidemiológico AIDST 2005; Ano II, no. 1. p. 3.
37. Cavalcanti MAS. Criptococose sistêmica endémica pela variedade gattii no meio norte do Brasil [Doctoral Dissertation]. Teresina: Universidade Federal do Piauí; 1997.
38. Goldman DL, Khine H, Abadi J, Lindenberg BS, Pirofski LA, Niang R, et ai. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 2001; 107:E66.
39. Moreira TA, Ferreira MS, Ribas RM, Borges AS. Criptococcose: estudo clínico-epidemiológico, laboratorial e das variedades do fungo em 96 pacientes. Rev Soc Bras Med Trop 2006; 39:255-8.
40. Lortholary O, Poizat G, ZellerV Neuville S, Boibieux A, Alvarez M, et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006; 20:2183-91.
41. Saag M, Graybill RJ, Larsen RA. Practical guidelines for the management of cryptococcal disease. Clin Infec Dis 2000; 30:710-8.
42. Mamidi A, DeSimone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection. J Neurovirol 2002, 8:158-67.
43. Benson CA, Kaplan JE, Masur H, PauA, Holmes KK; Centers for Disease Control and Prevention, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53(RR-15):1-112.